YASMIN CHAUDHRY: Open Payments
NPI 1801849377 · BEAR, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 35 payments from 19 companies in 2025. Trend: 2023 $557 · 2024 $692 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $98 |
| Indivior Inc. | 3 | $71 |
| Lilly USA, LLC | 4 | $70 |
| ABBVIE INC. | 3 | $65 |
| Braeburn Inc. | 3 | $51 |
| Hologic Sales and Service, LLC | 2 | $48 |
| Dexcom, Inc. | 2 | $46 |
| Gilead Sciences, Inc. | 2 | $40 |
| Corcept Therapeutics | 1 | $38 |
| Novo Nordisk Inc | 2 | $35 |
Products named: FREESTYLE LIBRE 3, SUBLOCADE, VRAYLAR, BRIXADI, APTIMA, Dexcom G6 Transmitter, Korlym, MOUNJARO.
Industry payments across DE — which companies pay providers there.
